Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach

Version 1 : Received: 8 May 2022 / Approved: 9 May 2022 / Online: 9 May 2022 (04:52:08 CEST)
Version 2 : Received: 15 June 2022 / Approved: 15 June 2022 / Online: 15 June 2022 (05:56:25 CEST)

How to cite: Osuagwu, U.L.; Langsi, R.; Ovenseri-Ogbomo, G.; Mashige, K.P.; Abu, E.K.; Envuladu, E.A.; Goson, P.C.; Ekpenyong, B.N.; Oloruntoba, R.; Chundung, M.A.; Charwe, D.D.; Timothy, C.G.; Ishaya, T.; Amiebenomo, O.M.; Lim, D.; Agho, K.E. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach. Preprints 2022, 2022050099. https://doi.org/10.20944/preprints202205.0099.v1 Osuagwu, U.L.; Langsi, R.; Ovenseri-Ogbomo, G.; Mashige, K.P.; Abu, E.K.; Envuladu, E.A.; Goson, P.C.; Ekpenyong, B.N.; Oloruntoba, R.; Chundung, M.A.; Charwe, D.D.; Timothy, C.G.; Ishaya, T.; Amiebenomo, O.M.; Lim, D.; Agho, K.E. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach. Preprints 2022, 2022050099. https://doi.org/10.20944/preprints202205.0099.v1

Abstract

Diabetes mellitus (DM) is associated with severe COVID-19 infection and complications. This study assessed COVID-19 vaccine acceptance and hesitancy in diabetes and explored reasons for nonvaccinating. A web-based cross-sectional survey using a mixed method approach was distributed to participants aged ≥18 years with self-reported DM in 11 Sub-Saharan African (SSA) countries from March–May 2021 corresponding to the early vaccine roll out period in most SSA countries. Responses to comments were analyzed for reasons for vaccine hesitancy and facilitators for vaccine uptake. Of the 73 participants with DM, 65.8% were males, older than 35 years (86.3%), had a post-secondary education (90%) and a significant proportion were from South Africa (39.7%), Nigeria (28.8%) and Ghana (13.7%). 64.4% had COVID-19 symptoms, 46.6% were tested for COVID-19 of which 19.2% tested positive. Few participants (6.8%) had taken COVID-19 vaccination, 65.8% were willing to take the vaccine, while 26.0% either refused or hesitated to take the vaccines. The main reasons identified for not taking the vaccine were: concerns about the vaccine safety, its effects, and efficacy, mistrust of the pharmaceutical companies, the conspiracy theories around the vaccines, the process of production, and personal belief of the participants. However, participants stated they would take the vaccine if given more education about it, receive positive feedback from those vaccinated, are rewarded for taking the vaccine or if vaccination becomes a condition for travel and employment. The findings of this study showed that uptake of COVID-19 vaccine was very low in this high-risk group. It is imperative that efforts to increase uptake of vaccine such as provision of education and relevant information, are made.

Keywords

diabetes; survey; sub-Saharan Africa; coronavirus; vaccine; hesitancy; refusal; qualitative; lockdown

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.